about
Repetitive long-term hyperbaric oxygen treatment (HBOT) administered after experimental traumatic brain injury in rats induces significant remyelination and a recovery of sensorimotor function.Transient global amnesia: diffusion-weighted imaging lesions and cerebrovascular diseaseTracking of magnetite labeled nanoparticles in the rat brain using MRIEvidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processReproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosisA comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.MRI for iron mapping in Alzheimer's disease.Evolution of white matter lesions.CT and MRI rating of white matter lesions.The natural course of MRI white matter hyperintensities.CT and MRI rating of white matter changes.Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis.Functional connectivity analyses using emulated and conventional resting-state data: parts versus the whole story.Diffusion imaging of the human spinal cord and the vertebral column.Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.Improved perfusion and tracer kinetic imaging using parallel imaging.Qualitative MRI: evidence of usual aging in the brain.Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis.The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".MRI to monitor treatment efficacy in multiple sclerosis.Progression of leukoaraiosis and cognition.Diagnosis of multiple sclerosis: progress and challenges.Pathophysiologic mechanisms in the development of age-related white matter changes of the brain.The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates.White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease.Fast patient workup in acute stroke using parallel imaging.Progression of cerebral white matter lesions -- clinical and radiological considerations.[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis].MRI in dementia.Magnetization transfer MR imaging in multiple sclerosis.Relevance of neuroimaging in the evaluation of cerebral ischemia.
P50
Q27331656-E0FFD3F3-0A9E-407E-8BEE-29C07B826782Q28285354-93C8EE8F-69E2-4DC2-B4DD-FCB10205A5BEQ28540929-741686D0-439C-4006-AFC6-48147AA88502Q29542960-D0133E55-7E38-481D-AB29-36B8D5939EEDQ30250336-D9B29E25-509D-4B5F-8986-4B9CCD693FADQ30580657-C4B681FB-EDDD-4A5C-A08C-F8F1A102771EQ30582882-39DCA321-822D-4ED8-B0B4-AB123F36F5D3Q30620703-759D9B25-FC1F-4944-B11C-B66CF02C6D17Q30655992-69374D13-82CC-4B09-BBB4-370E3E79FA90Q30661273-6956E4C1-3089-4D7A-A485-B88707E41695Q30680374-79555A4A-0AAB-4307-91D5-A0A6C9D4434AQ30680395-6E6548B4-7105-41B9-89A3-30C8D8F42A1BQ30744725-412EB087-12B6-4A47-83D2-0CBC1C99EF1FQ30750061-5CBA147E-4880-4BF3-8B38-E72FFD1195F7Q30750076-6DE525DE-F6AD-4A06-869E-73A18F17A300Q30753871-8806689E-A6C1-405A-9ED0-4F20B4F2A4BBQ30868897-1DFBE3E9-3A33-42F3-82F7-51CAD14A6821Q30899676-B2918625-194F-4D2B-AB03-27569CD328EAQ30926815-9FCE0C5C-E902-4D99-AB2C-82FD215D57F5Q30976530-74824C6D-8BAE-4BB0-8F20-9E178F6BCB47Q30996005-BA4E156D-8D7A-4AD1-926E-BC4829BDEAC6Q31030767-F4D4FAE8-56CC-499D-B448-2DCF77DD09BAQ31037155-52E6E625-0374-440E-A729-15073A7295D0Q31037583-FFC7D26D-467E-4D74-9FC3-627F1BCD1B98Q31042055-CA1619A0-3E46-4454-B07C-34B7AC308126Q31058235-3DD8B4A4-35FB-4736-8195-ED4A156D2D12Q31061704-B6915BDA-53B5-41BB-AB4C-D55615AE1C46Q31108872-29134EAA-3DA1-4312-8DD2-4946883B9F08Q31120637-3AEAD1A2-0412-40B3-928E-E93047D94048Q31144846-BE0ABA84-4933-4B3B-8C7C-3D30DDC2F56CQ32034487-A35AFAD2-3880-41F8-A616-CF33D78A18F5Q32040633-A1E1BCC0-964C-4A12-8056-F226D2D6130DQ32081575-59029E75-B1D6-4EE3-82EF-192C3BA27060Q33204660-6CA89953-7BEC-4764-B6B3-DE6A04FC6BABQ33207851-9843C7BF-D59B-4091-8D00-EB70F7BB4EEBQ33275442-20A63E7C-3B60-4999-91A2-5749F2E41C24Q33378123-BE5812D7-B48B-4AF6-96F5-6BE5E8F3B51AQ33389660-19AAA4F3-635F-489D-806C-46A704B0999EQ33390856-BA768F66-1F3D-4A06-8E2F-895B910D75C6Q33426281-A664FC0D-5641-45E1-ADAD-747B2325B4F3
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Franz Fazekas
@ast
Franz Fazekas
@en
Franz Fazekas
@es
Franz Fazekas
@nl
Franz Fazekas
@sl
type
label
Franz Fazekas
@ast
Franz Fazekas
@en
Franz Fazekas
@es
Franz Fazekas
@nl
Franz Fazekas
@sl
prefLabel
Franz Fazekas
@ast
Franz Fazekas
@en
Franz Fazekas
@es
Franz Fazekas
@nl
Franz Fazekas
@sl
P214
P106
P21
P214
P31
P496
0000-0001-8155-7799
P735
P7859
lccn-n98802454